Table 1

Association between pre- and post-chemotherapy fibrinogen levels and clinical characteristics
Characteristics pre-chemotherapy fibrinogen pre-chemotherapy fibrinogen
N (%) (g/L) (mean ± SD) p value

(g/L) (mean ± SD)

p value
Age
<60 95(59.4 %) 4.58 ± 1.28 0.053 4.44 ± 1.27 0.018
≥60 65(40.6 %) 5.06 ± 1.65 4.79 ± 1.27
gender
Male 102(63.8 %) 4.91 ± 1.53 0.041 4.72 ± 1.21 0.023
Female 58(36.2 %) 4.40 ± 1.29 4.34 ± 1.25
Stage
III 60(37.5 %) 4.895 ± 1.68 0.497 4.61 ± 1.35 0.851
IV 100(62.5 %) 4.639 ± 1.32 4.57 ± 1.24
Histological type
Adenocarcinoma 98(61.2 %) 4.69 ± 1.41 0.358 4.60 ± 1.28 0.677
Squamous carcinoma 34(21.3 %) 5.06 ± 1.72 4.36 ± 1.16
Others 28(17.5 %) 4.41 ± 1.28 4.78 ± 1.39
ECOG
0 105(65.6 %) 4.55 ± 1.38 0.051 4.33 ± 1.11 0.002
1 55(34.4 %) 5.04 ± 1.57 5.07 ± 1.44

Zhao et al.

Zhao et al. BMC Cancer 2012 12:330   doi:10.1186/1471-2407-12-330

Open Data